Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Discovery of new protein could provide new understanding of male fertility

Scientists have discovered a new enzyme involved in the degradation of proteins inside cells, a process that helps eliminate or recycle proteins that are no longer needed. The unexpected discovery, made by Marcus Groettrup, chair of the immunology department at the University of Constance, Konstanz, Germany, and colleagues, overthrows the idea that protein degradation is initiated by only one enzyme. Also, the new enzyme is very highly expressed in the testis, which could provide a new understanding of male fertility.

“We essentially found that cleanup in the cell is not supervised by one but by two proteins,” Groettrup says. “It is important because everything we know about this cleanup process assumes that only one enzyme initiates it. The second protein we discovered may either share some functions with the first one or do totally different things.”

The new study, to be published in the August 3 issue of the Journal of Biological Chemistry, was selected as a “Paper of the Week” by the journal’s editors, meaning that it belongs to the top one percent of papers reviewed in significance and overall importance.

Before being degraded, proteins are “tagged” with a small protein called ubiquitin. Three types of enzymes are involved in the tagging process. An enzyme called activating enzyme E1 first activates ubiquitin and binds to it. Then the ubiquitin is transferred to a second enzyme called ubiquitin-conjugating enzyme E2. And a third enzyme, called ubiquitin ligase E3 binds to both E2 and the protein to be degraded, so that E2 can transfer the ubiquitin to the protein. By binding to other ubiquitin-carrying E2 enzymes, E3 transfers many ubiquitins to the protein, signaling to the cell that the protein needs to be degraded.

... more about:
»UBE1L2 »Ubiquitin »degradation »enzyme »fertility »testis

Until now, only one type of E1 enzyme for ubiquitin has been known to exist in the human genome, while 34 E2 enzymes and 531 E3 enzymes have been discovered. Because of the large number of E2 or E3 enzymes that have been found, researchers are more likely to find another E2 or E3 enzyme than a new E1 enzyme, which explains why Goetrrup and his colleagues were very surprised to stumble upon one.

“You can picture E1 as the Federal Reserve Bank," Goettrup says. "Until now, scientists have shown that, in all the protein degradation processes that use ubiquitin, E1 is the master bank that distributes money (ubiquitin) to other banks (the E2 enzymes), which then give out credits to their clients (the E3 enzymes). What we found is another Federal Reserve Bank, bringing questions like: "What are the clients of this new master bank"' and 'Are there other master banks that we haven't found yet"' It makes us rethink protein degradation in completely new ways."

The scientists were searching for an enzyme similar to E1 that activates a protein that looks like ubiquitin called FAT10. Surprisingly, the enzyme they found could not activate FAT10 but instead activated ubiquitin itself. The researchers then tested whether this enzyme, which they called UBE1L2, also helped degrade proteins by working with E2 and E3 enzymes. They confirmed that this was indeed the case.

Groettrup and his team also tested whether UBE1L2 was – like the original E1 – expressed in all organs and tissues. They measured the expression levels of UBE1L2 in mice and found that the protein was expressed about five times more in the testis than other organs.

“Again, this was totally unexpected,” Goettrup says. “Unlike the first E1, UBE1L2 might have a specialized role in tissues and in particular in the testis. Going back to the previous analogy of the Federal Reserve Bank, this result shows that UBE1L2’s ‘main client banks’ may be in the testis and that UBE1L2 controls many of the protein degradation processes in that organ.”

Goettrup and colleagues are now planning to investigate which E2 and E3 enzymes work with UBE1L2 and determine whether they also work with the original E1. The scientists also would like to investigate a potential role for UBE1L2 in male fertility and determine why the enzyme is more highly expressed in testes than in ovaries.

ARTICLE: “UBE1L2, a novel E1 enzyme, specific for Ubiquitin,” by Christiane Pelzer, Ingrid Kassner, Konstantin Matentzoglu, Rajesh K. Singh, Hans-Peter Wollscheid, Martin Scheffner, Gunter Schmidtke, and Marcus Groettrup

MEDIA CONTACT: Marcus Groettrup, University of Constance, Konstanz, Germany; tel. +49 7531 88 2130; e-mail:

The American Society for Biochemistry and Molecular Biology is a nonprofit scientific and educational organization with over 11,900 members in the United States and internationally. Most members teach and conduct research at colleges and universities. Others conduct research in various government laboratories, nonprofit research institutions and industry. The Society’s student members attend undergraduate or graduate institutions.

Founded in 1906, the Society is based in Bethesda, Maryland, on the campus of the Federation of American Societies for Experimental Biology. The Society's purpose is to advance the science of biochemistry and molecular biology through publication of the Journal of Biological Chemistry, the Journal of Lipid Research, and Molecular and Cellular Proteomics, organization of scientific meetings, advocacy for funding of basic research and education, support of science education at all levels, and promoting the diversity of individuals entering the scientific work force.

Pat Pages | EurekAlert!
Further information:

Further reports about: UBE1L2 Ubiquitin degradation enzyme fertility testis

More articles from Life Sciences:

nachricht Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München

nachricht Second research flight into zero gravity
21.10.2016 | Universität Zürich

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>